CATHERINE LIGHTFOOT: Open Payments
NPI 1235694183 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 6 companies in 2025. Trend: 2023 $365 · 2024 $301 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $45 |
| Daiichi Sankyo Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ozempic, Enhertu, VRAYLAR, VOQUEZNA, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
